WASHINGTON, June 12 (TNSLrpt) -- The Congressional Research Service issued the following report (No. R48982) entitled "The 2026 Childhood Immunization Schedule:" (Continued from Part 1 of 2) * * * Discussion of HHS's Justifications Comparison of the U.S. Vaccination Schedule with Those of Other Countries An individual country's public health system may weigh a range of factors when determining and developing vaccine recommendations. These considerations for a specific vaccine recommendation commonly include sociodemographic characteristics more PR

WASHINGTON, June 12 (TNSLrpt) -- The Congressional Research Service issued the following report (No. R48982) entitled "The 2026 Childhood Immunization Schedule:" (Continued from Part 3 of 2) * * * Potential Implications of the Revised Schedule As mentioned at the beginning of this report, a federal district court stayed the 2026 revised childhood immunization schedule in American Academy of Pediatrics v. Kennedy, meaning that the effective date of the revised schedule is postponed while the court considers the case./116 The district court a more PR

LA JOLLA, California, June 11 [Category: Environment] -- The Scripps Research Institute posted the following news: * * * A fentanyl countermeasure that adapts to combat future black-market drugs * Scripps Research scientists developed a vaccine that teaches the immune system to rapidly neutralize fentanyl and new emerging synthetic fentanyl analogs. June 11, 2026 LA JOLLA, CA- Fentanyl and related variants of the synthetic opioid kill more Americans each year than car accidents and gun violence combined. In too-high doses, the drugs hij more PR

SHATIN, Hong Kong, June 12 (TNSjou) -- The Chinese University of Hong Kong issued the following news release: * * * CUHK co-led landmark global study shows over half of advanced ALK-positive lung cancer patients stay progression-free at seven years Revealing potential to transform specific oncogene-driven lung cancer into a chronic disease - The Chinese University of Hong Kong (CUHK)'s Faculty of Medicine (CU Medicine) co-led a landmark seven-year international Phase 3 clinical trial in lung cancer with multiple cancer centres worldwide. T more PR

WASHINGTON, June 13 -- The Democratic National Committee posted the following news release on June 12, 2026: * * * IN THE STATES: As Trump Declares "I Love the Inflation," Working Families Throughout America Are Paying More, Earning Less, and Cutting Back With Donald Trump declaring "I love the inflation" and bragging that "I don't think about Americans' financial situations," it's no surprise that people in states throughout the country are paying more, earning less, and cutting back. As Trump and his extreme Republicans continue their assa more PR

FAIRFAX, Virginia, June 8 -- Inova, a healthcare provider, issued the following news release: * * * Inova Schar Cancer President John Deeken, MD, named to Modern Healthcare's 50 Most Influential Clinical Executives List John Deeken, MD, President of Inova Schar Cancer and co-director of the Inova Schar Head and Neck Cancer Program, has been named to Modern Healthcare's 2026 list of the "50 Most Influential Clinical Executive." This national recognition honors physician and clinical leaders whose impact extends beyond their own organizations more PR

GALVESTON, Texas, June 12 -- The University of Texas Medical Branch issued the following news release: * * * Nature Medicine Commission launch highlights closing day of Texas Brain Economy Summit * Global leaders in neuroscience, public policy, economics, and healthcare announced the launch of the Nature Medicine Commission on Brain Health for Economic Resilience on Wednesday, June 10, during the second and closing day of the Texas Brain Economy Summit at TMC3 in the Texas Medical Center in Houston. The announcement marked a major milesto more PR